vTv Therapeutics Inc (VTVT)
23.63
-0.07
(-0.29%)
USD |
NASDAQ |
May 03, 16:00
23.70
+0.06
(+0.28%)
Pre-Market: 20:00
vTv Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.009M |
| September 30, 2022 | |
| June 30, 2022 | 0.009M |
| March 31, 2022 | 2.00M |
| December 31, 2021 | 0.009M |
| September 30, 2021 | 3.00M |
| June 30, 2021 | 0.009M |
| March 31, 2021 | 0.987M |
| December 31, 2020 | 6.399M |
| September 30, 2020 | 0.007M |
| June 30, 2020 | |
| March 31, 2020 | 0.008M |
| December 31, 2019 | 0.007M |
| September 30, 2019 | 0.008M |
| June 30, 2019 | 1.828M |
| March 31, 2019 | 0.921M |
| December 31, 2018 | 4.522M |
| September 30, 2018 | 3.375M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.473M |
| March 31, 2018 | 2.064M |
| December 31, 2017 | 0.233M |
| September 30, 2017 | 0.015M |
| June 30, 2017 | 0.013M |
| March 31, 2017 | 0.03M |
| December 31, 2016 | 0.038M |
| September 30, 2016 | 0.038M |
| June 30, 2016 | 0.182M |
| March 31, 2016 | 0.376M |
| December 31, 2015 | 0.226M |
| September 30, 2015 | 0.133M |
| June 30, 2015 | 0.11M |
| March 31, 2015 | 0.05M |
| December 31, 2014 | 0.934M |
| September 30, 2014 | 0.40M |
| June 30, 2014 | 0.201M |
| March 31, 2014 | 0.014M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.007M
Minimum
Dec 2019
6.399M
Maximum
Dec 2020
1.098M
Average
0.009M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Altimmune Inc | 0.037M |
| Palatin Technologies Inc | 2.034M |
| Oragenics Inc | -- |
| Viking Therapeutics Inc | -- |
| G1 Therapeutics Inc | 14.87M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.478M |
| Total Expenses (Quarterly) | 4.707M |
| EPS Diluted (Quarterly) | -1.31 |
| Enterprise Value | 54.37M |
| Earnings Yield | -41.09% |
| Normalized Earnings Yield | -42.32 |